True Wealth Design’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.26K Sell
294
-123
-29% -$1.66K ﹤0.01% 1397
2026
Q1
$5.78K Buy
417
+16
+4% +$223 ﹤0.01% 1150
2025
Q4
$5.63K Buy
401
+99
+33% +$1.39K ﹤0.01% 1042
2025
Q3
$4.22K Buy
+302
New +$4.35K ﹤0.01% 1148

Other funds holding RDY

True Wealth Design's RDY Position: Q2 2026 in Review

True Wealth Design reduced its Dr. Reddy's Laboratories (RDY) stake by 29% in Q2 2026, selling an estimated $1.66K and leaving 294 shares worth $4.26K. The position accounts for ﹤0.01% of the portfolio, ranked #1397.

True Wealth Design first reported a position in RDY in Q3 2025 and has held it in 4 quarters since. The position peaked at $5.78K in Q1 2026. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • True Wealth Design held 294 shares of Dr. Reddy's Laboratories worth $4.26K as of Q2 2026.
  • True Wealth Design sold 123 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $1.66K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #1397 holding.
  • True Wealth Design first reported a position in Dr. Reddy's Laboratories in Q3 2025 and has held it in 4 quarters since.
  • True Wealth Design's Dr. Reddy's Laboratories position peaked at $5.78K in Q1 2026.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.